EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Aztreonam plus ceftazidime-avibactam for post-neurosurgical meningitis due to Stenotrophomonas maltophilia

Jonathan Wong-So, Sophie Magréault, Étienne Carbonnelle, Vincent Jullien, Maxime Desgrouas, Thierry Boulain, François Barbier iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00172-25 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Jonathan Wong-So und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire d'Orleans, Orléans, France. Hauptthemen laut MEDLINE: Ceftazidime, Stenotrophomonas maltophilia, Aztreonam, Azabicyclo Compounds. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical evidence is lacking regarding the efficacy of aztreonam-avibactam in severe infections involving Stenotrophomonas maltophilia . We report a case of post-neurosurgical meningitis due to S. maltophilia (minimal inhibitory concentration of aztreonam plus avibactam, 4/4 µg/mL) clinically and microbiologically cured with a combination of aztreonam and ceftazidime-avibactam (2 g and 2 g/500 mg q8h, 3 h simultaneous infusions). Therapeutic drug monitoring showed adequate concentrations of aztreonam and avibactam in the cerebrospinal fluid at each time point over the 14-day treatment duration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftazidimeStenotrophomonas maltophiliaAztreonamAzabicyclo CompoundsAnti-Bacterial AgentsGram-Negative Bacterial InfectionsMeningitis, BacterialHumansDrug CombinationsMicrobial Sensitivity TestsMaleMiddle Aged

Stichwörter der Autor:innen

Stenotrophomonas maltophiliaaztreonamceftazidime-avibactamcentral nervous system infectionstherapeutic drug monitoring

Substanzen

CeftazidimeAztreonamAzabicyclo Compoundsavibactam, ceftazidime drug combinationAnti-Bacterial AgentsDrug Combinations

Autor:innen und Institutionen

  • Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire d'Orleans, Orléans, France.
  • Laboratoire de Pharmacologie, Hôpital Jean Verdier, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Équipe IAME, INSERM, Université Sorbonne Paris Nord, Bobigny, France.
  • Laboratoire de Microbiologie, Centre Hospitalier Universitaire d'Orleans, Orléans, France.

ORCID-Profile: François Barbier

Zitieren

APA

Wong-So, J., Magréault, S., Carbonnelle, É., Jullien, V., Desgrouas, M., Boulain, T., & Barbier, F. (2025). Aztreonam plus ceftazidime-avibactam for post-neurosurgical meningitis due to Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00172-25

Vancouver

Wong-So J, Magréault S, Carbonnelle É, Jullien V, Desgrouas M, Boulain T, et al. Aztreonam plus ceftazidime-avibactam for post-neurosurgical meningitis due to Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00172-25

BibTeX
@article{WongSo2025,
  author = {Wong-So, Jonathan and Magréault, Sophie and Carbonnelle, Étienne and Jullien, Vincent and Desgrouas, Maxime and Boulain, Thierry and Barbier, François},
  title = {Aztreonam plus ceftazidime-avibactam for post-neurosurgical meningitis due to Stenotrophomonas maltophilia},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00172-25}
}
Kostenlos starten →